LifeX 2050 Longevity Income ETF (BATS:LFAI) Sees Large Growth in Short Interest

LifeX 2050 Longevity Income ETF (BATS:LFAI – Get Free Report) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totaling 753 shares, an increase of 91.1% from the August 31st total of 394 shares. Based on an average daily volume of 91 shares, the short-interest ratio is presently 8.3 days. Approximately 2.5% of the company’s stock are short sold.

Hedge Funds Weigh In On LifeX 2050 Longevity Income ETF

An institutional investor recently bought a new stake in LifeX 2050 Longevity Income ETF stock. Citadel Advisors LLC bought a new stake in shares of LifeX 2050 Longevity Income ETF (BATS:LFAI – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 5,438 shares of the company’s stock, valued at approximately $819,000. Citadel Advisors LLC owned approximately 18.13% of LifeX 2050 Longevity Income ETF at the end of the most recent reporting period.

LifeX 2050 Longevity Income ETF Trading Down 0.2%

LFAI stock opened at $139.81 on Wednesday. LifeX 2050 Longevity Income ETF has a 1 year low of $139.81 and a 1 year high of $159.55. The stock has a 50-day simple moving average of $144.87 and a 200-day simple moving average of $148.45.

About LifeX 2050 Longevity Income ETF

(Get Free Report)

The Stone Ridge 2050 Longevity Income ETF (LFAI) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund actively manages US Treasury exposure, aiming to provide predictable cashflows through 2050. The fund is designed to appeal to investors born in 1950 and reaching age 100. LFAI was launched on Sep 13, 2024 and is issued by Stone Ridge.

Further Reading

Receive News & Ratings for LifeX 2050 Longevity Income ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeX 2050 Longevity Income ETF and related companies with MarketBeat.com's FREE daily email newsletter.